FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← MRNA · Moderna, Inc.
DEFA14AThe Ballot

Moderna, Inc. files DEFA14A

Filed Oct 20, 2025 · 8mo ago · Accession 0001682852-25-000065

Plain English

DEFA14A filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Moderna, Inc.
Ticker
MRNA
CIK
1682852
Form type
DEFA14A
Filing date
Oct 20, 2025
Report date
—
Document
factsheet.htm
Size
270 KB

More from MRNA

8-KBylaw Amendment · Shareholder VoteMay 11, 20268-KResults of OperationsMay 1, 202610-QThe RecordMay 1, 2026DEF 14ADEFINITIVE PROXY STATEMENTMar 16, 2026DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALSMar 16, 20268-KMaterial AgreementMar 5, 2026